High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy

ABSTRACT:

SUBMITTER: Parissenti A 

PROVIDER: S-EPMC12337404 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature